000 01946cam a2200337 a 4500
003 EG-GiCUC
005 20250223030300.0
008 100926s2010 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.12.02.Ph.D.2010.Fa.A
100 0 _aFatma Baiuomy Rashedy Abdallah
245 1 0 _aAntibody directed enzyme prodrug therapy :
_bMolecular studies on carboxypeptidase G2 , production by DNA shuffling of novel variants of CPG2 for more efficient cancer treatment /
_cFatma Baiuomy Rashedy Abdallah ; Supervised Abdalla M. Negm , Ahmed I. Amien
246 1 5 _aعلاج مرض السرطان بإستخدام جسم مضاد موجه ومحمل بإنزيم الكربوكسى بيبتيديزجى2 :
_bدراسات جزيئية على هذا الانزيم : وانتاج مشابهات لهذا الانزيم ذو كفاءة اعلى من خلال تكنولوجيا قص وخلط وإعادة لصق الجين
260 _aCairo :
_bFatma Baiuomy Rashedy Abdallah ,
_c2010
300 _a246P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry
520 _aGlucarpidase (former name : carboxypeptidase G2, or CPG2 ) is a bacterial enzyme that is widely used in detoxification of the cytotoxic drug methotrexate and in Antibody Directed Enzme Prodrug Therapy ( ADEPT ) for cancer treatment . In this study we report three achievements in relation to the CPG2 enzyme and the ADEPT for cancer treatment
530 _aIssued also as CD
653 4 _aADEPT
653 4 _aCPG2 overexpression
653 4 _aSynthetic carboxypeptidase G2
700 0 _aAbdalla M. Negm ,
_eSupervisor
700 0 _aAhmed I. Amien ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aFatma
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c31480
_d31480